Pro Dex Inc Quick Ratio (PDEX) starting from the first quarter 2026 to first quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Pro dex Inc   (NASDAQ: PDEX)

Pro Dex Inc 's Quick Ratio

PDEX's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Pro Dex Inc 's Cash & cash equivalent grew by 34.88 % in the Q1 2026 sequentially, while Current Liabilities decreased, this led to improvement in Pro Dex Inc 's Quick Ratio to 1.1, Quick Ratio remained below Pro dex Inc average.

Within Medical Equipment & Supplies industry 119 other companies have achieved higher Quick Ratio than Pro Dex Inc in first quarter 2026. While Quick Ratio total ranking in the first quarter 2026 has deteriorated compared to the prior quarter from 276 to 2163.

Explain Quick Ratio?
How much Cash & cash equivalents PDEX´s has?
What are PDEX´s Current Liabilities?




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/PDEX/financial-strength
https://api.csimarket.com/api/v1/companies/PDEX/fundamentals
https://api.csimarket.com/api/v1/companies/PDEX/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
PDEX Quick Ratio (Sep 30 2026)
Q1
(Jun 30 2026)
Q4
(Mar 31 2026)
Q3
(Dec 31 2025)
Q2
(Sep 30 2025)
Q1
Y / Y Current Liabilities Change 30.75 %
Y / Y Cash & cash equivalent Change 34.75 %
Quick Ratio MRQ 1.1
PDEX's Total Ranking # 2163
Seq. Current Liabilities Change -1.54 %
Seq. Cash & cash equivalent Change 34.88 %



Quick Ratio first quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 120
Healthcare Sector # 669
Overall Market # 2163


Quick Ratio Statistics
High Average Low
6.02 1.74 0.18
(Sep 30 2018)   (Dec 31 2022)




Financial Statements
Pro Dex Inc 's Current Liabilities $ 13 Millions Visit PDEX's Balance sheet
Pro Dex Inc 's Cash & cash equivalent $ 14 Millions Visit PDEX's Balance sheet
Source of PDEX's Sales Visit PDEX's Sales by Geography


Cumulative Pro Dex Inc 's Quick Ratio

PDEX's Quick Ratio for the trailling 12 Months

PDEX Quick Ratio

(Sep 30 2026)
12 Months
(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth -6.9 %
Y / Y Cash & cash equivalent TTM Growth 19.06 %
Quick Ratio TTM 0.81
Total Ranking TTM # 2862
Seq. Current Liabilities TTM Growth 6.09 %
Seq. Cash & cash equivalent TTM Growth 9.38 %


On the trailing twelve months basis PDEX Cash & cash equivalent grew by 34.75 % in Q1 2026 year on year, faster than Current Liabilities, this led to increase in in Pro Dex Inc 's Quick Ratio to 0.81, Quick Ratio remained below PDEX average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 205 other companies have achieved higher Quick Ratio than Pro Dex Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2026 from 643 to 4068.

Explain Quick Ratio?
How much Cash & cash equivalents PDEX´s has?
What are PDEX´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 206
Healthcare Sector # 903
Within the Market #


trailing twelve months Quick Ratio Statistics
High Average Low
2.42 0.96 0.1
(Mar 31 2019)   (Dec 31 2025)




Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Medical Equipment & Supplies Industry Quick RatioSep 30 2026 MRQ Cash & cash equivalentSep 30 2026 MRQ Current Liabilities
Sharps Technology Inc   2.82 $ 7.478  Millions$ 2.650  Millions
Edwards Lifesciences Corporation  2.81 $ 4,683.700  Millions$ 1,664.300  Millions
Mimedx Group Inc   2.81 $ 120.791  Millions$ 43.031  Millions
Streamex Corp   2.80 $ 26.248  Millions$ 9.382  Millions
Pulse Biosciences Inc   2.74 $ 36.725  Millions$ 13.395  Millions
Staar Surgical Co  2.73 $ 206.414  Millions$ 75.541  Millions
Medinotec Inc   2.68 $ 2.584  Millions$ 0.963  Millions
Glaukos Corp  2.66 $ 337.478  Millions$ 126.726  Millions
Pulmonx Corporation  2.57 $ 53.245  Millions$ 20.739  Millions
Beta Bionics Inc   2.48 $ 81.551  Millions$ 32.836  Millions
Irhythm Holdings Inc   2.46 $ 560.719  Millions$ 228.025  Millions
Genedx Holdings Corp   2.38 $ 170.118  Millions$ 71.403  Millions
Apyx Medical Corp  2.37 $ 25.777  Millions$ 10.870  Millions
Atricure Inc   2.23 $ 187.031  Millions$ 83.972  Millions
Vivani Medical Inc   2.22 $ 14.591  Millions$ 6.585  Millions
Electromed Inc   2.19 $ 15.875  Millions$ 7.261  Millions
Inspire Medical Systems inc   1.96 $ 190.803  Millions$ 97.438  Millions
Aethlon Medical Inc   1.91 $ 6.487  Millions$ 3.403  Millions
Merit Medical Systems Inc  1.90 $ 503.551  Millions$ 265.083  Millions
Nephros Inc   1.89 $ 4.546  Millions$ 2.409  Millions
Fractyl Health Inc   1.82 $ 31.515  Millions$ 17.345  Millions
Warby Parker Inc   1.77 $ 287.914  Millions$ 162.226  Millions
Anika Therapeutics Inc   1.68 $ 44.957  Millions$ 26.725  Millions
EBR Systems, Inc.  1.63 $ 85.415  Millions$ 52.539  Millions
Beyond Air Inc   1.61 $ 17.121  Millions$ 10.632  Millions
Intuitive Surgical Inc   1.60 $ 4,042.500  Millions$ 2,533.000  Millions
Tactile Systems Technology Inc   1.58 $ 75.110  Millions$ 47.499  Millions
Edap Tms Sa  1.56 $ 56.269  Millions$ 36.070  Millions
Neuraxis Inc   1.55 $ 4.477  Millions$ 2.888  Millions
Envista Holdings Corporation  1.42 $ 1,158.800  Millions$ 816.300  Millions

Date modified: 2026-10-30T13:19:57+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.